Accueil   Diary - News   All news CarThera to present data from phase 1/2a study

CarThera to present data from phase 1/2a study

Paris, France, May 10, 2017 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that Dr. Ahmed Idbaih, AP-HP principal investigator of the Phase 1/2a clinical trial (NCT02253212) on ultrasound induced Blood-Brain Barrier opening will reveal preliminary safety and efficacy data at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago (June 2-6).




The clinical trial involved 21 patients with recurrent glioblastoma (GBM), who have all been treated with SonoCloud® low-intensity pulse ultrasound in a total of 65 sessions.



Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to More details are available by clicking here I agree